These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

900 related articles for article (PubMed ID: 25132759)

  • 1. MiRNA as potential biomarkers and therapeutic targets for gastric cancer.
    Shin VY; Chu KM
    World J Gastroenterol; 2014 Aug; 20(30):10432-9. PubMed ID: 25132759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysregulation of miRNAs as a signature for diagnosis and prognosis of gastric cancer and their involvement in the mechanism underlying gastric carcinogenesis and progression.
    Ahadi A
    IUBMB Life; 2020 May; 72(5):884-898. PubMed ID: 32078236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs as potential biomarkers for gastric cancer.
    Liu HS; Xiao HS
    World J Gastroenterol; 2014 Sep; 20(34):12007-17. PubMed ID: 25232237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of microRNAs in gastric cancer.
    Ishiguro H; Kimura M; Takeyama H
    World J Gastroenterol; 2014 May; 20(19):5694-9. PubMed ID: 24914330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNAs in gastric cancer: Biomarkers and therapeutic targets.
    Ghafouri-Fard S; Vafaee R; Shoorei H; Taheri M
    Gene; 2020 Oct; 757():144937. PubMed ID: 32640300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastric adenocarcinoma has a unique microRNA signature not present in esophageal adenocarcinoma.
    Chen Z; Saad R; Jia P; Peng D; Zhu S; Washington MK; Zhao Z; Xu Z; El-Rifai W
    Cancer; 2013 Jun; 119(11):1985-93. PubMed ID: 23456798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An overview of the multifaceted roles of miRNAs in gastric cancer: Spotlight on novel biomarkers and therapeutic targets.
    Wu X; Shen J; Xiao Z; Li J; Zhao Y; Zhao Q; Cho CH; Li M
    Biochem Pharmacol; 2019 May; 163():425-439. PubMed ID: 30857828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miRNA signature associated with outcome of gastric cancer patients following chemotherapy.
    Kim CH; Kim HK; Rettig RL; Kim J; Lee ET; Aprelikova O; Choi IJ; Munroe DJ; Green JE
    BMC Med Genomics; 2011 Nov; 4():79. PubMed ID: 22112324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential Diagnostic, Prognostic and Therapeutic Targets of MicroRNAs in Human Gastric Cancer.
    Tsai MM; Wang CS; Tsai CY; Huang HW; Chi HC; Lin YH; Lu PH; Lin KH
    Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27322246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging roles of non-coding RNAs in gastric cancer: Pathogenesis and clinical implications.
    Xie SS; Jin J; Xu X; Zhuo W; Zhou TH
    World J Gastroenterol; 2016 Jan; 22(3):1213-23. PubMed ID: 26811659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrative network analysis reveals active microRNAs and their functions in gastric cancer.
    Tseng CW; Lin CC; Chen CN; Huang HC; Juan HF
    BMC Syst Biol; 2011 Jun; 5():99. PubMed ID: 21703006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated miRNA profiling and bioinformatics analyses reveal potential causative miRNAs in gastric adenocarcinoma.
    Zhang X; Peng Y; Jin Z; Huang W; Cheng Y; Liu Y; Feng X; Yang M; Huang Y; Zhao Z; Wang L; Wei Y; Fan X; Zheng D; Meltzer SJ
    Oncotarget; 2015 Oct; 6(32):32878-89. PubMed ID: 26460735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysregulation of non-coding RNAs in gastric cancer.
    Yang Q; Zhang RW; Sui PC; He HT; Ding L
    World J Gastroenterol; 2015 Oct; 21(39):10956-81. PubMed ID: 26494954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in molecular biomarkers for gastric cancer: miRNAs as emerging novel cancer markers.
    Wu HH; Lin WC; Tsai KW
    Expert Rev Mol Med; 2014 Jan; 16():e1. PubMed ID: 24456939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three-microRNA signature identified by bioinformatics analysis predicts prognosis of gastric cancer patients.
    Zhang C; Zhang CD; Ma MH; Dai DQ
    World J Gastroenterol; 2018 Mar; 24(11):1206-1215. PubMed ID: 29568201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant expression of microRNAs in gastric cancer and biological significance of miR-574-3p.
    Su Y; Ni Z; Wang G; Cui J; Wei C; Wang J; Yang Q; Xu Y; Li F
    Int Immunopharmacol; 2012 Aug; 13(4):468-75. PubMed ID: 22683180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relationship between the expression level of miR-29c and biological behavior of gastric cancer].
    Ma XQ; Wang LP; Luo QC; Cai JC
    Zhonghua Zhong Liu Za Zhi; 2013 May; 35(5):325-30. PubMed ID: 24054006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical significance of downregulation of mir-124-3p, mir-146a-5p, mir-155-5p and mir-335-5p in gastric cancer tumorigenesis.
    Li H; Xie S; Liu M; Chen Z; Liu X; Wang L; Li D; Zhou Y
    Int J Oncol; 2014 Jul; 45(1):197-208. PubMed ID: 24805774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of MicroRNA Deregulation and MicroRNA Targets in Gastric Cancer.
    Irmak-Yazicioglu MB
    Oncol Res Treat; 2016; 39(3):136-9. PubMed ID: 27031864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of microRNA in gastric malignancy.
    Nishizawa T; Suzuki H
    Int J Mol Sci; 2013 Apr; 14(5):9487-96. PubMed ID: 23629677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.